SIMS STRATEGIES, LLC

Lobbying for GLAXOSMITHKLINE, INC. · Pharmaceutical Company

Filing 4th Quarter - Report

4th Quarter (Oct 1 - Dec 31) 2025 · District of Columbia · Senate · $40,000.00 income · posted Jan 20, 2026

Lobbying activity 2

Pharmacy

Issues related to prescription drugs, vaccines, and Pharmacy Benefit Managers.

Medicare/Medicaid

Issues related to prescription drugs, vaccines, and Pharmacy Benefit Managers.

Source: federal Lobbying Disclosure Act filing. Bills are parsed from the activity descriptions.